NASDAQ
3.98USD
-0.09 (-2.25%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
1.4M
P/E
—
EPS
—
Beta
0.60
52W range
3.61-648
Day range
3.90–4.17
Open
3.98
Prev close
4.07
Volume
15.1K
Avg volume
32K
Dividend
0.00
IPO
2011-01-26
https://www.globenewswire.com/news-release/2026/08/18/3347260/0/en/22nd-century-group-to-participate-in-the-hc-wainwright-conference-on-september-15-2026.html · 8/18/2026+0.20
https://seekingalpha.com/article/4901982-22nd-century-group-inc-xxii-q1-2026-earnings-call-prepared-remarks-transcript · 5/9/2026+0.00
https://www.globenewswire.com/news-release/2026/04/23/3279802/0/en/22nd-Century-Group-Expands-Reduced-Nicotine-Platform-Through-New-Testing-Services-Agreement-with-North-Carolina-State-University.html · 4/23/2026+0.60
https://seekingalpha.com/article/4886183-22nd-century-group-inc-xxii-q4-2025-earnings-call-prepared-remarks-transcript · 3/26/2026+0.00
https://www.defenseworld.net/2026/03/24/22nd-century-group-xxii-expected-to-announce-earnings-on-tuesday.html · 3/24/2026
https://www.benzinga.com/trading-ideas/long-ideas/26/01/50260669/top-3-defensive-stocks-that-could-blast-off-this-quarter-2 · 1/30/2026+0.50
https://www.globenewswire.com/news-release/2026/01/12/3217374/0/en/22nd-Century-to-Participate-in-the-Needham-Annual-Growth-Conference-January-16-2026.html · 1/12/2026+0.20
https://seekingalpha.com/article/4837412-22nd-century-group-inc-xxii-q3-2025-earnings-call-transcript · 11/4/2025+0.00
https://www.benzinga.com/trading-ideas/long-ideas/25/08/47256268/top-3-risk-off-stocks-which-could-rescue-your-portfolio-this-month · 8/21/2025-0.20
22nd Century Group, Inc. is an agricultural biotechnology firm dedicated to mitigating the risks associated with tobacco use and improving health and wellness through advanced plant science. The company serves the life science and consumer product sectors. Its innovations include ultra-low nicotine tobacco and cigarette offerings, marketed under the VLN King and VLN Menthol King brands, as well as SPECTRUM research cigarettes used in independent scientific investigations. Furthermore, 22nd Century Group collaborates with Keygene N.V. to cultivate hemp and cannabis plants engineered for superior cannabinoid content and enhanced agricultural characteristics, intended for medical, therapeutic, farming, and other applications. Established in 1998, the company is based in Buffalo, New York.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
